Stock Track | ACADIA Pharmaceuticals Plummets 6.49% in Pre-Market Following Quarterly Revenue Shortfall

Stock Track

Feb 26

ACADIA Pharmaceuticals Inc. (ACAD) experienced a significant pre-market plunge, with its stock falling 6.49%.

The sharp decline follows the company's latest earnings report, which revealed a mixed financial performance. While ACADIA's adjusted earnings per share of $0.14 for the quarter beat analyst estimates, its quarterly sales of approximately $284 million fell short of consensus expectations. This revenue miss appears to be the primary driver behind the negative investor sentiment in the pre-market session.

According to the earnings summary, analyst earnings estimates for the company had fallen by about 4.3% over the prior three months. Despite the current setback, the average analyst rating on the shares remains "buy," with a median 12-month price target significantly above the recent closing price.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1180485605"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1180485605\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1180485605?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-26 17:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180485605","market":"sg","top_or_hot":-1,"title":"Stock Track | ACADIA Pharmaceuticals Plummets 6.49% in Pre-Market Following Quarterly Revenue Shortfall","media":"Stock Track","content":"<p>ACADIA Pharmaceuticals Inc. (ACAD) experienced a significant pre-market plunge, with its stock falling 6.49%.</p><p>The sharp decline follows the company's latest earnings report, which revealed a mixed financial performance. While ACADIA's adjusted earnings per share of $0.14 for the quarter beat analyst estimates, its quarterly sales of approximately $284 million fell short of consensus expectations. This revenue miss appears to be the primary driver behind the negative investor sentiment in the pre-market session.</p><p>According to the earnings summary, analyst earnings estimates for the company had fallen by about 4.3% over the prior three months. Despite the current setback, the average analyst rating on the shares remains \"buy,\" with a median 12-month price target significantly above the recent closing price.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | ACADIA Pharmaceuticals Plummets 6.49% in Pre-Market Following Quarterly Revenue Shortfall</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | ACADIA Pharmaceuticals Plummets 6.49% in Pre-Market Following Quarterly Revenue Shortfall\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-26 17:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ACADIA Pharmaceuticals Inc. (ACAD) experienced a significant pre-market plunge, with its stock falling 6.49%.</p><p>The sharp decline follows the company's latest earnings report, which revealed a mixed financial performance. While ACADIA's adjusted earnings per share of $0.14 for the quarter beat analyst estimates, its quarterly sales of approximately $284 million fell short of consensus expectations. This revenue miss appears to be the primary driver behind the negative investor sentiment in the pre-market session.</p><p>According to the earnings summary, analyst earnings estimates for the company had fallen by about 4.3% over the prior three months. Despite the current setback, the average analyst rating on the shares remains \"buy,\" with a median 12-month price target significantly above the recent closing price.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ACAD","symbol_name":"阿卡迪亚","start_time":0,"source_url":"","article_id":"1180485605","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180485605","pubTimestamp":1772098368,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"ACADIA Pharmaceuticals Inc. (ACAD) experienced a significant pre-market plunge, with its stock falling 6.49%.The sharp decline follows the company's latest earnings report, which revealed a mixed...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ACAD":"阿卡迪亚"},"translate_title":"个股追踪|季度营收亏空阿卡迪亚制药盘前暴跌6.49%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACAD":1},"content_text":"ACADIA Pharmaceuticals Inc. (ACAD) experienced a significant pre-market plunge, with its stock falling 6.49%.The sharp decline follows the company's latest earnings report, which revealed a mixed financial performance. While ACADIA's adjusted earnings per share of $0.14 for the quarter beat analyst estimates, its quarterly sales of approximately $284 million fell short of consensus expectations. This revenue miss appears to be the primary driver behind the negative investor sentiment in the pre-market session.According to the earnings summary, analyst earnings estimates for the company had fallen by about 4.3% over the prior three months. Despite the current setback, the average analyst rating on the shares remains \"buy,\" with a median 12-month price target significantly above the recent closing price.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}